21 December 2023 in Acta Biomaterialia
With the lack of minimally invasive tools for probing neuronal systems across spatiotemporal scales, understanding the working mechanism of the nervous system and limited assessments available are imperative to prevent or treat neurological disorders. In particular, nanoengineered neural interfaces can provide a solution to this technological barrier. This review covers recent surface engineering approaches, including nanoscale surface coatings, and a range of topographies from the microscale to the nanoscale, primarily focusing on neural-interfaced biosystems. Specifically, the immobilization of bioactive molecules to fertilize the neural cell lineage, topographical engineering to induce mechanotransduction in neural cells, and enhanced cell-chip coupling using three-dimensional structured surfaces are highlighted. Advances in neural interface design will help us understand the nervous system, thereby achieving the effective treatments for neurological disorders. STATEMENT OF SIGNIFICANCE: • This review focuses on designing bioactive neural interface with a nanoscale chemical modification and topographical engineering at multiscale perspective. • Versatile nanoscale surface coatings and topographies for neural interface are summarized. • Recent advances in bioactive materials applicable for neural cell culture, electrophysiological sensing, and neural implants are reviewed.
16 July 2025 in Biomaterials
Flexible neural probes with integrated recording, optical stimulation, and drug delivery capabilities offer unprecedented access to neural circuit dynamics. However, their long-term utility is compromised by foreign body responses that isolate recording sites from target neurons. This study introduces photoinitiated chemical vapor deposition (piCVD) as a transformative approach to neural interface stability through ultrathin (<100 nm) anti-fouling coatings. Unlike conventional hydrogel coatings that impair electrical signal transmission, our piCVD-applied poly(2-hydroxyethyl methacrylate-co-ethylene glycol dimethacrylate) coating maintains electrical functionality by preserving low impedance while providing superior anti-fouling properties. In vitro protein adsorption studies demonstrated near-complete resistance to both albumin and fibrinogen compared to uncoated surfaces, with the coating maintaining stability even after 24 h of sonication-durability unachievable with conventional wet-chemistry methods. When evaluated in mouse models over three months, the coated probe maintained high-quality spontaneous neural recordings and optically evoked potentials throughout the study period, with signal-to-noise ratios improving from 18.0 at week 1-20.7 at week 13. This performance significantly correlates with 66.6 % reduction in glial scarring, 84.6 % increase in neuronal preservation compared to uncoated probes. The specific combination of CVD methodology and optimized copolymer composition achieves long-term stability, representing a significant advance over the typical one-month limitation of conventional coatings. These results establish piCVD antifouling coatings as an enabling technology for chronic neural interfaces in both basic neuroscience research and emerging neuroprosthetic applications.
17 July 2024 in Advanced Materials
Human pluripotent stem cells (hPSCs), encompassing human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), hold immense potential in regenerative medicine, offering new opportunities for personalized cell therapies. However, their clinical translation is hindered by the inevitable reliance on xenogeneic components in culture environments. This study addresses this challenge by engineering a fully synthetic, xeno‐free culture substrate, whose surface composition is tailored systematically for xeno‐free culture of hPSCs. A functional polymer surface, pGC2 (poly(glycidyl methacrylate‐grafting‐guanidine‐co‐carboxylic acrylate)), offers excellent cell‐adhesive properties as well as non‐cytotoxicity, enabling robust hESCs and hiPSCs growth while presenting cost‐competitiveness and scalability over Matrigel. This investigation includes comprehensive evaluations of pGC2 across diverse experimental conditions, demonstrating its wide adaptability with various pluripotent stem cell lines, culture media, and substrates. Crucially, pGC2 supports long‐term hESCs and hiPSCs expansion, up to ten passages without compromising their stemness and pluripotency. Notably, this study is the first to confirm an identical proteomic profile after ten passages of xeno‐free cultivation of hiPSCs on a polymeric substrate compared to Matrigel. The innovative substrate bridges the gap between laboratory research and clinical translation, offering a new promising avenue for advancing stem cell‐based therapies.
24 February 2026 in Small Structures
Effective therapeutic delivery and diagnostic monitoring at cellular levels are constrained by biological barriers including stratum corneum, extracellular matrix, and plasma membranes. Conventional approaches such as viral vectors and liposomes face limitations including inadequate penetration, immunogenicity, and invasiveness. High‐aspect‐ratio nanostructures, including nanoneedles and microneedles, address these challenges through their unique geometries enabling direct, minimally invasive cellular access. This review examines high‐aspect‐ratio nanostructure technologies from fabrication strategies to therapeutic and diagnostic applications. We discuss bottom‐up synthesis, top‐down lithographic methods, and integrative approaches enabling precise control over geometry, mechanical properties, and surface functionalization. Mechanotransduction applications reveal how these architectures modulate cellular behavior through mechanosensitive pathways and enable phenotypic control. Recent advances have expanded applications to precision medicine through intracellular delivery of genetic engineering tools to challenging cell populations including immune cells and neurons. Hollow, porous, and surface‐functionalized architectures enable controlled therapeutic release and targeted cellular reprogramming. Diagnostic applications demonstrate capabilities for intracellular sensing and continuous physiological monitoring. Convergence with artificial intelligence promises adaptive, personalized therapeutic protocols. However, challenges including scalable manufacturing, long‐term biocompatibility, and regulatory translation must be addressed to realize clinical potential. This review positions high‐aspect‐ratio nanostructures as foundational platforms for next‐generation precision medicine and personalized healthcare.